237 related articles for article (PubMed ID: 15727723)
1. Treatment of the metabolic syndrome: the impact of lifestyle modification.
Pritchett AM; Foreyt JP; Mann DL
Curr Atheroscler Rep; 2005 Mar; 7(2):95-102. PubMed ID: 15727723
[TBL] [Abstract][Full Text] [Related]
2. Successful control of dyslipidemia in patients with metabolic syndrome: focus on lifestyle changes.
Stone NJ
Clin Cornerstone; 2006; 8 Suppl 1():S15-20. PubMed ID: 16903165
[TBL] [Abstract][Full Text] [Related]
3. Physical training improves insulin resistance syndrome markers in obese adolescents.
Kang HS; Gutin B; Barbeau P; Owens S; Lemmon CR; Allison J; Litaker MS; Le NA
Med Sci Sports Exerc; 2002 Dec; 34(12):1920-7. PubMed ID: 12471297
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.
Hansel B; Bonnefont-Rousselot D; Orsoni A; Bittar R; Giral P; Roussel R; Marre M; Mohammedi K; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(5):1172-81. PubMed ID: 27678434
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome: therapeutic considerations.
Grundy SM
Handb Exp Pharmacol; 2005; (170):107-33. PubMed ID: 16596797
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome: controversial but useful.
Stolar M
Cleve Clin J Med; 2007 Mar; 74(3):199-202, 205-8. PubMed ID: 17375800
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of the metabolic syndrome among obese adolescents enrolled in a multidisciplinary weight management program: clinical correlates and response to treatment.
Wickham EP; Stern M; Evans RK; Bryan DL; Moskowitz WB; Clore JN; Laver JH
Metab Syndr Relat Disord; 2009 Jun; 7(3):179-86. PubMed ID: 19450141
[TBL] [Abstract][Full Text] [Related]
8. PCSK9 levels in abdominally obese men: association with cardiometabolic risk profile and effects of a one-year lifestyle modification program.
Arsenault BJ; Pelletier-Beaumont E; Alméras N; Tremblay A; Poirier P; Bergeron J; Després JP
Atherosclerosis; 2014 Oct; 236(2):321-6. PubMed ID: 25128757
[TBL] [Abstract][Full Text] [Related]
9. The effect of dietary changes on distinct components of the metabolic syndrome in a young Sri Lankan population at high risk of CVD.
Guess N; Wijesuriya M; Vasantharajah L; Gulliford M; Viberti G; Gnudi L; Karalliedde J
Br J Nutr; 2016 Aug; 116(4):719-27. PubMed ID: 27358019
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome: diagnosis and treatment.
Zieve FJ
Clin Cornerstone; 2004; 6 Suppl 3():S5-13. PubMed ID: 15707265
[TBL] [Abstract][Full Text] [Related]
11. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
12. High cardiometabolic risk in healthy Chilean adolescents: associations with anthropometric, biological and lifestyle factors.
Burrows R; Correa-Burrows P; Reyes M; Blanco E; Albala C; Gahagan S
Public Health Nutr; 2016 Feb; 19(3):486-93. PubMed ID: 25990645
[TBL] [Abstract][Full Text] [Related]
13. Reducing cardiovascular risk factors in postmenopausal women through a lifestyle change intervention.
Carels RA; Darby LA; Cacciapaglia HM; Douglass OM
J Womens Health (Larchmt); 2004 May; 13(4):412-26. PubMed ID: 15186658
[TBL] [Abstract][Full Text] [Related]
14. Drug treatment of metabolic syndrome.
Altabas V
Curr Clin Pharmacol; 2013 Aug; 8(3):224-31. PubMed ID: 22950955
[TBL] [Abstract][Full Text] [Related]
15. The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia.
Chan DC; Barrett PH; Watts GF
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):369-85. PubMed ID: 24840265
[TBL] [Abstract][Full Text] [Related]
16. Effects of a carbohydrate-restricted diet with and without supplemental soluble fiber on plasma low-density lipoprotein cholesterol and other clinical markers of cardiovascular risk.
Wood RJ; Fernandez ML; Sharman MJ; Silvestre R; Greene CM; Zern TL; Shrestha S; Judelson DA; Gomez AL; Kraemer WJ; Volek JS
Metabolism; 2007 Jan; 56(1):58-67. PubMed ID: 17161227
[TBL] [Abstract][Full Text] [Related]
17. Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Andersen RE; Wadden TA; Bartlett SJ; Zemel B; Verde TJ; Franckowiak SC
JAMA; 1999 Jan; 281(4):335-40. PubMed ID: 9929086
[TBL] [Abstract][Full Text] [Related]
18. Prevention and treatment of the metabolic syndrome.
Daskalopoulou SS; Mikhailidis DP; Elisaf M
Angiology; 2004; 55(6):589-612. PubMed ID: 15547646
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome is strongly associated with chronic subclinical inflammation in patients achieving optimal low-density lipoprotein-cholesterol levels in secondary prevention of cardiovascular disease.
Matsuo Y; Hashizume T; Shioji S; Akasaka T
Circ J; 2008 Dec; 72(12):2046-50. PubMed ID: 18946171
[TBL] [Abstract][Full Text] [Related]
20. Lifestyle intervention can prevent weight gain during menopause: results from a 5-year randomized clinical trial.
Simkin-Silverman LR; Wing RR; Boraz MA; Kuller LH
Ann Behav Med; 2003 Dec; 26(3):212-20. PubMed ID: 14644697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
